
10 Risks to Assess When Choosing a Work Visa for International Staff
Hiring international staff can open the door to a broader talent pool, global innovation, and a competitive edge. But with opportunity comes complexity, especially when selecting the right U.S. work visa. This article explores the key risk factors HR professionals, hiring managers and founders must consider when choosing a work visa for international hires.
The first step in visa selection is determining whether the candidate qualifies for the chosen visa type. Misalignment here can lead to denials, audits, or worse.
Common Risks: Misunderstanding degree requirements for H-1B visas
Assuming 'extraordinary ability' under O-1 without strong documentation
Using L-1 without sufficient intra-company history
Mitigation Tip: Use corporate immigration platforms like Boundless, which help automate eligibility screening and prepare documentation for common work visas, including H-1B, L, and O visas.
U.S. immigration timelines are notoriously unpredictable. Premium processing may shorten some timelines, but bottlenecks in consulates or USCIS offices can delay onboarding by weeks or months.
Common Risks: H-1B cap lottery delays or rejections
EB green cards are subject to country-specific backlogs (India and China, especially)
Security checks and document requests prolong approval
Mitigation Tip: Plan visa timelines 6–12 months in advance. Monitor Visa Bulletin updates to USCIS processing stages in order to identify delays early.
Once a visa is approved, the employer must maintain compliance with Department of Labor and USCIS rules. Failure to do so can lead to fines or disqualification from future visa sponsorship.
Common Risks: Incorrect wage level filings for H-1B
Incomplete Public Access Files (PAFs)
Misclassification of visa status (e.g., interns misrepresented as employees)
Mitigation Tip: Work with HR platforms and legal partners that maintain digital audit trails. Use structured workflows for onboarding, compensation documentation, and visa updates.
Visa processing can be expensive. Fees vary based on visa type, premium processing, legal counsel, and ongoing compliance.
Average Costs (approximate): H-1B: $5,000–$10,000
L-1: $4,000–$8,000
O-1: $6,000–$12,000
EB Green Cards: $10,000–$20,000 over multiple years
Mitigation Tip: Use transparent, flat-fee platforms for predictable budgeting when hiring international talent. More complex immigration cases might require an immigration attorney or in-house counsel.
Visa constraints can affect job satisfaction, mobility, and retention. Employees waiting years for a green card or dependent on employer sponsorship may feel stuck, or leave when options arise.
Common Risks: Long wait times for EB-2/EB-3 green cards
Spouses unable to work (dependent visa restrictions)
Employees lured by companies offering better immigration pathways
Mitigation Tip: Provide long-term sponsorship roadmaps and support (EB categories), invest in employee experience, and communicate clearly about options and timelines.
Not every visa aligns with your company's size, structure, or global goals. A mismatch can introduce friction.
Examples: L-1 requires a qualifying relationship between foreign and U.S. entities
O-1 demands extensive documentation of individual acclaim
H-1B relies on a lottery (March–April), limiting spontaneity
Mitigation Tip: Consider hybrid solutions: hire offshore temporarily, use remote-first models, or explore cap-exempt H-1Bs (e.g., through nonprofit partnerships or research institutions).
U.S. immigration policy shifts with each administration, and even legal visa holders can be affected by sudden regulatory changes.
Recent Trends: Travel bans, visa suspensions, or executive orders under the Trump administration
Increased scrutiny of STEM-related H-1Bs
Green card backlog reform debates in congress
Mitigation Tip: Monitor immigration policy closely and build redundancy into your talent strategy (e.g., remote teams in Canada or EU). Platforms like Boundless Immigration also offer compliance updates and government alerts.
Top talent often travels with spouses or children. A restrictive dependent policy may deter candidates.
Considerations: H-4 spouses may not be eligible to work without an EAD (Employment Authorization Document)
School access and local licensing for dependents
Permanent residency path for family members
Mitigation Tip: Include family support in relocation packages and immigration planning.
Errors or embellishments in visa applications can lead to denials or blacklisting, even if unintentional.
Examples: Inaccurate job descriptions or inflated credentials
Fake degrees or work experience (especially from third-party firms)
Misuse of Optional Practical Training (OPT) or Curricular Practical Training (CPT)
Mitigation Tip: Conduct thorough reference and credential checks. Centralize application materials and vet with legal oversight.
Can your chosen visa process scale as your company grows?
Questions to ask: Is your legal partner or platform equipped to handle dozens of visas at once?
Will your HR systems track visa milestones at scale?
Can your business model handle recurring sponsorship costs?
Mitigation Tip: Invest in tools for end-to-end visa lifecycle management. Choose partners who can scale with your hiring roadmap.
TIME BUSINESS NEWS

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
H&M sees second quarter 2025 sales, operating profit dip
Swedish multinational clothing retail company H&M recorded fall in its operating profit to Skr5.9bn ($624.3m) for the second quarter ended on 31 May. The operating margin falling to 10.4% from 11.9%. This decline is primarily due to a reduced gross margin and unfavourable currency exchange impacts. After-tax profits stood at Skr3.96bn compared to Skr5.06bn previously, resulting in earnings of Skr2.48 per share, a decrease from Skr3.15 per share. Gross profit for the second quarter of 2025 was Skr31.43bn, resulting in a gross margin of 55.4% compared to 56.3% the previous year. The margin suffered mainly due to a more expensive US dollar, high freight costs, and the company's investments in enhancing the customer offering. Despite these challenges, the external factors are expected to turn favourable in the second half of the year. H&M experienced a 1% increase in sales in local currencies, despite operating with 4% fewer stores than the previous year. When excluding store closures, sales saw a 3% rise. However, when converted to Swedish krona (Skr), net sales decreased to Skr56.71bn from Skr59.61bn, influenced by a strong Skr which had a six percentage point negative currency translation effect. H&M CEO Daniel Ervér said: 'Our plan, with its focus on the product offering, the shopping experience and brand, is again confirmed by the progress we see. The positive development in important areas such as online, H&M womens-wear and H&M Move, as well as continued focus on good cost control, will contribute to a profitable sales development.' Selling and administrative expenses were Skr25.49bn, a slight increase in local currencies by 2%. In the first half of the year, net sales were up 1% in local currencies, with Skr112.05bn in net sales. Gross profit was Skr58.59bn, with a gross margin of 52.3%. Operating profit for the half-year was Skr7.12bn, with a margin of 6.4%. June 2025 sales are expected to increase by 3% in local currencies compared to the same month last year, despite a negative calendar effect. Ervér added: 'In uncertain times with cautious consumers we monitor macroeconomic and geopolitical developments closely and continuously adapt both the customer offering and the business to meet our customers' needs in the best way.' H&M is planning to enter the Brazilian market, with both physical and online stores, in the second half of the year. Portfolio brands, particularly COS, have shown growth, and the company remains focused on improving the product offering and shopping experience. Sustainability efforts have been integrated into operations, yielding recognition from an environmental organisation. Ervér added: 'With a clear plan, a strong financial position, good cost control and committed employees, we see good opportunities for long-term, sustainable and profitable growth.' "H&M sees second quarter 2025 sales, operating profit dip" was originally created and published by Retail Insight Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
4 hours ago
- Yahoo
BioMarin's ROCTAVIAN Shows Sustained Efficacy, Safety Over 5 Years for Severe Hemophilia A
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most undervalued US stocks according to analysts. On June 24, BioMarin Pharmaceutical Inc. presented new 5-year data from its Phase 3 GENEr8-1 trial at the 33rd Congress of the International Society on Thrombosis and Haemostasis/ISTH in Washington, D.C., which took place from June 21 to 25. The data reinforced the long-term efficacy and safety of ROCTAVIAN (valoctocogene roxaparvovec-rvox) as a gene therapy for severe hemophilia A. The GENEr8-1 trial is the longest and largest hemophilia gene therapy study to date, and demonstrated sustained Factor VIII (FVIII) expression and durable bleed control 5 years after a single treatment with ROCTAVIAN. A pharmaceutical plant manufacturing a proprietary synthetic oral form of a C-type natriuretic peptide. FVIII activity remained consistent with previously reported results. Importantly, no new safety signals were observed over the 5-year study period. Across all 134 participants who received ROCTAVIAN in the study, there were no cases of FVIII inhibitors or thromboembolic events, and no treatment-related malignancies were observed. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a biotechnology company that develops and commercializes therapies for life-threatening rare diseases and medical conditions internationally. While we acknowledge the potential of BMRN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio


Politico
10 hours ago
- Politico
Trump pushes Thune to crack down on wind and solar in megabill
President Donald Trump is urging Senate Majority Leader John Thune to crack down on tax credits for wind and solar energy as part of the GOP megabill, siding with House conservatives who want to phase out those credits more quickly, according to three people familiar with the negotiations. The late-stage effort has involved direct conversations between Trump and Thune over the past two days. The intervention from Trump centers around a technical provision that could determine whether hundreds of planned projects are able to qualify for the wind and solar incentives, according to the people granted anonymity because they were not authorized to speak publicly about the conversations. The president's involvement has emerged as a complicating factor as Republicans aim to start voting on the megabill as soon as Saturday. Sen. Kevin Cramer (R-N.D.), a close Trump ally, confirmed that Trump is directly involved in the push to further temper the Inflation Reduction Act credits. 'I talked to POTUS about it this morning and he certainly wants the renewables out ASAP,' Cramer said Friday. The approach pushed by Trump would match restrictive language in the House-passed reconciliation bill, H.R. 1, that would determine eligibility for wind and solar investment and production tax credits based on when those projects enter into service. It's a departure from Senate Finance Committee language backed by moderates allowing projects to receive credits based on when they begin construction. It's unclear whether Thune plans to include the so-called 'placed in service' standard in the final bill text. Doing so would put moderate senators who have pushed a slower schedule for sunsetting those incentives in a major bind, forcing them to choose between rejecting Trump's agenda or allowing the gutting of tax credits that could lead to canceled projects, job losses and higher electricity prices in their states. Thune's office and the White House did not immediately respond to requests for comment on Friday. Trump's new push follows his Truth Social post last weekend declaring, 'I HATE 'GREEN TAX CREDITS' IN THE GREAT, BIG, BEAUTIFUL BILL.' Renewable energy industry officials and advocates argue that a 'placed in service' requirement is difficult for energy project developers because their timelines could be derailed by permitting delays, snags in connecting projects to the grid and other factors outside their control. Such a requirement would functionally end the credits for many planned projects, they say. Reverting to more restrictive placed in service language would likely see pushback from moderate senators such as Sen. Lisa Murkowski (R-Alaska), who said Thursday that such a move would be 'disastrous in my state.' Another moderate who has pushed back on IRA rollbacks, Sen. Thom Tillis (R-N.C.), declined to say Friday night whether he had heard about a decision on placed in service language, but called the Senate Finance Committee's approach 'a more rational way of doing it.' 'There are lawsuits, regulatory hurdles and other things that would make it virtually impossible to get [projects] in service' even if they are essentially complete and would otherwise qualify, Tillis said. Some Senate conservatives have backed the change, which they said will help keep Republicans' campaign promise to end the Inflation Reduction Act subsidies. Texas Sen. Ted Cruz said earlier this week 'there is a strong commitment to end the Green New Deal subsidies by the end of President Trump's term' — an objective, he said, 'that we're working hard to accomplish.' The effort has been supported by outside conservative voices in recent days, including Alex Epstein, a vocal opponent of wind and solar subsidies who has met with Senate Republicans in recent weeks. Epstein said Friday night that Trump is 'aware that the Senate had watered down in some significant way what the House did.' But he said moving to a placed in service standard is not a done deal and he is 'not letting up myself until I see a law with this in it.' Leading Trump officials like Interior Secretary Doug Burgum, who also chairs the National Energy Dominance Council, and Energy Secretary Chris Wright, have also repeatedly criticized wind and solar energy, arguing those intermittent resources are unreliable and overly reliant on tax subsidies. In a post to X Friday night, Burgum wrote that Trump 'promised to reverse the Biden administration's disastrous energy policies, and the One Big Beautiful Bill delivers on this promise by ending the Green New Scam and investing in reliable, affordable baseload power!'